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Abstract
Background: Cluster randomized trials (CRTs) randomize participants in groups, rather than as individuals and are
key tools used to assess interventions in health research where treatment contamination is likely or if individual
randomization is not feasible. Two potential major pitfalls exist regarding CRTs, namely handling missing data and
not accounting for clustering in the primary analysis. The aim of this review was to evaluate approaches for
handling missing data and statistical analysis with respect to the primary outcome in CRTs.
Methods: We systematically searched for CRTs published between August 2013 and July 2014 using PubMed, Web
of Science, and PsycINFO. For each trial, two independent reviewers assessed the extent of the missing data and
method(s) used for handling missing data in the primary and sensitivity analyses. We evaluated the primary analysis
and determined whether it was at the cluster or individual level.
Results: Of the 86 included CRTs, 80 (93 %) trials reported some missing outcome data. Of those reporting missing
data, the median percent of individuals with a missing outcome was 19 % (range 0.5 to 90 %). The most common
way to handle missing data in the primary analysis was complete case analysis (44, 55 %), whereas 18 (22 %) used
mixed models, six (8 %) used single imputation, four (5 %) used unweighted generalized estimating equations, and
two (2 %) used multiple imputation. Fourteen (16 %) trials reported a sensitivity analysis for missing data, but most
assumed the same missing data mechanism as in the primary analysis. Overall, 67 (78 %) trials accounted for
clustering in the primary analysis.
Conclusions: High rates of missing outcome data are present in the majority of CRTs, yet handling missing data in
practice remains suboptimal. Researchers and applied statisticians should carry out appropriate missing data
methods, which are valid under plausible assumptions in order to increase statistical power in trials and reduce the
possibility of bias. Sensitivity analysis should be performed, with weakened assumptions regarding the missing data
mechanism to explore the robustness of results reported in the primary analysis.
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Background
In cluster randomized trials (CRTs), groups of partici-
pants, rather than individuals, are randomized to interven-
tion arms. CRTs are often adopted to reduce treatment
contamination or if individual randomization is unsuitable
and are an increasingly popular approach in comparative
effectiveness research [1–4]. In cluster-level allocation,
participants cannot be assumed as independent because of
the similarity among participants within the same cluster
or cluster characteristics, leading to intracluster correl-
ation, or equivalently, between-cluster variation [3]. Two
potential pitfalls with respect to CRTs are handling miss-
ing data and not accounting for clustering in the primary
analysis.
Missing data decreases power and precision and can
lead to bias by compromising randomization. For ex-
ample, treatment arm imbalance with respect to missing
data is likely to introduce bias when the outcome is re-
lated to the reason for patient withdrawal. Even if missing
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outcome data are balanced across treatment arms, differ-
ing reasons for the missing outcome can cause bias [5].
Reviews of individually randomized controlled trials have
discovered that most trials have some missing outcome
data [6, 7]. Few reports have discussed missing data in
CRTs, despite its high likelihood and the recognition that
it poses a serious threat to research validity, as discussed
by the National Research Council and the Patient Cen-
tered Outcomes Research Institute [5, 8].
Missing data mechanisms are commonly classified into
the following three categories. Data are considered to be
missing completely at random (MCAR) if missingness is
independent of the observed outcomes and covariates.
MCAR is a strong assumption and is not likely in most
clinical trials. A more sensible assumption is missing at
random (MAR), where missingness does not depend on
unobserved data after conditioning on the observed data.
Data are termed missing not at random (MNAR) if miss-
ingness is dependent on unobserved data values even
after conditioning on fully observed data [9, 10].
The most common approach for handling missing out-
come data is a complete case analysis, which excludes in-
dividuals with missing data. This approach yields unbiased
estimation if missingness is independent of the outcome,
given the covariates [11]. Additional approaches include
imputation (single and multiple) and model-based
methods. Single imputation strategies, such as the popular
last observation carried forward (LOCF) used in longitu-
dinal studies, or mean substitution, replaces missing data
with a single number, which underestimates uncertainty
[12, 13]. LOCF also makes unlikely assumptions about an
individual’s trajectory and can lead to either under- or
overestimation of treatment effects [14].
Under the MAR assumption, multiple imputation (MI)
considers uncertainty by filling in missing data from a dis-
tribution of likely values. Analysis is performed on each
dataset and the results combined using specified algo-
rithms. Most implementations of MI are single level, ignor-
ing the multilevel structure of CRTs. Multilevel MI
incorporates the lack of independence found within clusters
due to the hierarchical data structure found in CRTs [15].
Likelihood based mixed models are valid for MAR
data if the model is specified correctly, while unweighted
GEE are valid under MCAR if there are a large number
of clusters [16, 17]. In order to make a valid complete
case analysis under the MAR assumption, inverse prob-
ability weighting (IPW) weights complete cases with the
inverse of their probability of being observed [18]. Al-
though IPW is relatively simple to perform with mono-
tone missing data, it is prone to large weights, which
cause unstable estimates and high variance [10].
The second difficulty regarding CRTs is accounting for
clustering in the primary analysis. Ignoring clustering
can lead to confidence intervals that are too narrow and
increased type I error rates [19, 20]. In order to account
for clustering, analysis can be performed at the cluster
level or at the individual level. Cluster-level analysis re-
duces observations within a cluster to an aggregate value
and then analyzes each independent data point [20, 21].
Although cluster level analysis alleviates the issue of
dependent data, reducing all observations within a cluster
to a single summary measure decreases the sample size
and power. Analyses at the individual level using general
linear models (GLMs) account for non-independent ob-
servations within clusters through robust standard errors
or adjust using the design effect, an inflation factor used
to achieve the same power of an individually randomized
trial [22]. Modeling techniques such as generalized esti-
mating equations (GEE) [23] and mixed models [24] expli-
citly involve intracluster correlation in the modeling
process, which enables a more realistic model of the clus-
tered data [24, 25]. Although these models can reduce
bias by controlling for confounding at the individual
level, they require a higher sample size of a large
number of clusters [1, 17, 21].
There have been several reviews on methodological
aspects of CRTs (see for example, Simpson et al. [26]
and Campbell et al. [27], and the references therein).
Diaz-Ordaz et al. [28] reviewed the imputation methods
used to handle missing data in CRTs but did not distin-
guish whether a complete case analysis, GEE, or mixed
model was used to handle missing data in the primary
analysis, as these approaches provide valid estimates
under differing missing data assumptions. Thus, our ob-
jective was to provide a comprehensive review of how
missing data are being dealt with in CRTs. The primary
aims of our review were to accomplish the following:
1. Identify the proportion of CRTs with missing data at
the cluster and individual level.
2. Examine the analytical approaches for the primary
analysis to find out whether
a. whether missing data had been accommodated
and
b. whether clustering had been accounted for.
3. Identify the proportion of CRTs reporting a
sensitivity analysis for missing data.
Secondary aims included assessing the techniques for
achieving balance in CRTs (stratification, matching, or
minimization), the differences between observed and ex-
pected attrition rates, and the intracluster correlation.
Methods
This study was a systematic review of a sample of CRTs
published between August 2013 and July 2014. Our meth-
odological strategy was based on guidelines from the
Preferred Reporting Items for Systematic Reviews and
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Meta-Analysis (PRISMA) statement (See Additional file 1
for compliance details) [29]. We have reported a detailed
protocol for this study elsewhere [30].
Eligibility criteria
Eligible studies were restricted to CRTs published in
English between August 2013 and July 2014. We included
all types of CRTs with human participants, including
stepped wedge trials that were reported in the databases
listed below [31, 32]. We excluded trial protocols, non- or
quasi-experimental designs, secondary trial reports, cost-
effectiveness reports, and studies where no individual-level
data were collected. We also excluded trials where the pri-
mary outcome was survival, as time-to-event analyses han-
dle censored data differently than other types of data.
Literature search and study selection
Two authors (MF and SH) electronically searched for
studies found in PubMed, Web of Science (all databases),
and PsycINFO. Titles and abstracts were searched con-
taining the terms “cluster randomized [randomised],”
cluster and trial, “community trial,” “community random-
ized [randomised],” or “group randomized [randomised].”
Two independent reviewers (MF and SH) screened titles
and abstracts, removed duplicates, and screened full texts.
Both reviewers (MF and SH) and the senior author
(MB) performed pilot testing of the data extraction form.
All papers used for piloting were included in the system-
atic review. The reviewers extracted data from each trial
using a standardized, pilot-tested form. Disagreements
over study eligibility or data extraction were resolved by
discussion or with the assistance of a third reviewer
(MB) when needed.
Sample Size
Based on previous literature, it was estimated that about
90 % of trials would report some missing outcome data
[6, 7]. Using the formula for a 95 % confidence interval
(CI) for a proportion, we estimated that a sample size of
86 papers would result in an acceptable 95 % CI for the
hypothesized 90 % of studies having some missing out-
come data (95 % CI of 84 to 96).
Analysis
We defined the number of clusters (and participants) in
each trial as the number of clusters (and participants) at
randomization. We computed the average number of
participants per cluster by dividing the number of partic-
ipants by the number of clusters.
Description and handling of missing data
We evaluated the degree of missing data and the
method(s) for handling missing data in the primary ana-
lysis for each trial. The primary analysis was defined as
the main analysis of the primary outcome. When multiple
primary outcomes were reported, we used the first out-
come listed in the methods section. For primary outcomes
measured repeatedly, we used the final follow-up time
point to calculate the missing proportion, unless a differ-
ent time point was specified for the primary analysis.
The proportion of clusters with a missing outcome was
calculated as the number of entire clusters with a missing
outcome (generally due to the entire cluster dropping out)
divided by the number of clusters randomized. Clusters
that were randomized but failed to recruit were consid-
ered missing. A similar calculation was carried out for the
proportion of participants with a missing outcome. In
cases where an entire cluster dropped out, the missing
data rate was included in our calculation of missing partic-
ipants. If the trial had longitudinal data, we calculated the
missing rate at the last time point or time point of the pri-
mary analysis if specified. Of those who reported some
missing data, we identified the statistical methods used to
handle missing data, classified into the following categor-
ies: complete case, single imputation (such as worst case
or LOCF), MI (single level or multilevel), GEE, mixed
model or IPW. Technically, mixed models and GEE are
considered complete case analyses. However, we make the
distinction because these are model-based methods.
Mixed models are valid under MAR, and GEE can be
modified to be valid under MAR. We also reported
methods for missing data for trials indicating greater than
or less than 10 % missing data at the individual level. We
indicated that a trial presented a sample size calculation if
there was enough detail for replication. We recorded
whether sample size calculations accounted for missing
data, and compared observed and expected attrition rates
with the mean absolute difference. If a range was reported
for attrition rates, we used the upper bound.
Sensitivity analysis for missing data
We computed the number of trials that reported perform-
ing a sensitivity analysis and determined the method(s)
used to deal with missing data in any sensitivity analysis.
Sensitivity analysis was defined as any analysis performed
to assess the robustness of the primary results due to
changes in assumptions regarding missing outcome data.
We also reported methods for sensitivity analysis for trials
indicating greater than or less than 10 % missing data at
the individual level. We quantified the number of trials
that weakened the missingness assumption of their
primary analysis (MCAR→MAR→MNAR) to perform
their sensitivity analysis as suggested by the Panel on
Handling Missing Data in Clinical Trials [10].
Accounting for clustering in the primary analysis
For each trial, we calculated the proportion of CRTs per-
forming an individual-level or cluster-level analysis and
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whether the analysis accounted for clustering. Individual
level analyses were categorized into the following
groups: basic inferential test (such as t-test or chi-
square)/GLM (such as linear or logistic regression),
GEE, or mixed model. The analysis accounted for clus-
tering if the basic inferential test or GLM obtained ro-
bust standard errors or was adjusted using the design
effect, if GEE introduced an exchangeable correlation
structure for clusters, or if the mixed model used clusters
as a random effect. Basic inferential tests/GLMs could also
be carried out as a cluster-level analysis. We examined
whether the primary analysis was unadjusted, adjusted for
baseline variables, adjusted for balance variables such as
stratification, or adjusted for additional covariates.
The intracluster correlation coefficient (ICC) measures
the degree of similarity among responses within a cluster
and is defined as the proportion of total variance due to
between-cluster variation. The coefficient of variation
(CV) is an alternate measure of between-cluster variabil-
ity and is defined by the ratio of the standard deviation
of cluster sizes to the mean cluster size [3]. We recorded
whether trials accounted for clustering in sample size
calculations and compared the observed and expected
ICCs (or CVs) with the mean absolute difference. If a
range was reported for the ICC (or CV), we used the
upper bound.
Results
We identified 3,674 records through our electronic data-
base search after removing 2,164 duplicates. We
screened 1,510 of the remaining records, of which, 1,049
were excluded, based on titles or abstracts, as not meet-
ing our eligibility criteria. We examined the full texts of
the remaining 461 trials and excluded a further 59 trials,
as they did not meet eligibility criteria. Of the 402 eli-
gible reports, we used six for piloting and randomly se-
lected 80 others, thereby including 86 trials in the
analyses (Fig. 1). The full list of the included studies is
given in Additional file 2.
Table 1 presents the general characteristics of the in-
cluded trials. In total, the median number of clusters
randomized was 24, with a range of 2 to 1,552. Three
trials were unclear in the number of clusters random-
ized. The median number of individuals included was
688, with a range of 49 to 117,100. The average number
of individuals per cluster ranged from 1 to 1,105. Of the
65 trials that collected the outcome repeatedly, 36
(55 %) used all of the information in the primary analysis
by treating the outcome as a repeated measurement,
while 29 (45 %) were analyzed at a single time point.
Forty-four (51 %) trials used balance techniques to en-
sure balance after randomization. Stratification was the
most common method (27, 61 %), a subset of which also
used matching (1) and minimization (1). Fourteen
(32 %) of the trials carrying out balance methods used
matching, and three (7 %) used minimization.
Description and handling of missing data
Twenty-seven (31 %) trials reported having whole clus-
ters missing in the primary analysis (Table 2). Of these,
the median amount of clusters missing was 7 %, with a
range of 0.8 to 51 %. Three trials had an unclear number
of clusters missing. Reasons for whole clusters missing
included closures, natural disasters, a lack of eligible par-
ticipants, and an inability to retrieve data. Figure 2 dis-
plays the proportions of included individuals with
missing outcomes. Eighty (93 %) trials reported having
some missing data at the individual level. Of these trials,
the median amount of missing individual level data was
19 %, with a range of 0.5 to 90 %. Eight trials were un-
clear in the amount of individual-level missing data. Of
the trials reporting some missing data, 61 (76 %) re-
ported reasons for individuals missing, two (2 %) re-
ported missing data due to missing covariates in the
adjusted analyses, and 17 (22 %) were unclear or did not
report reasons for individuals missing.
The most common approach for handling missing data
in the primary analysis was a complete case analysis (44,
55 %) (Table 3). Eighteen (22 %) trials used mixed
models. Six (8 %) carried out single imputation methods:
three used worst-case imputation, two used LOCF, and
one used baseline observation carried forward. Four
(5 %) trials used unweighted GEE. Two (2 %) trials per-
formed MI, although neither used multilevel methods. A
MAR assumption for the primary analysis was made in
20 (25 %) of the trials with missing data.
Of the 58 trials reporting more than 10 % missing data
at the individual level, 31 (53 %) used complete case ana-
lysis, 17 (29 %) used mixed models, five (9 %) used single
imputation, two (3 %) used MI, and three (3 %) used
methods that were unclear. Of the 14 trials reporting
less than 10 % missing data at the individual level, 10
(71 %) used complete case, three (21 %) used un-
weighted GEE, and one (7 %) used single imputation.
Sixty (70 %) trials presented a sample size calculation,
of which 28 (47 %) accounted for missing data via sam-
ple size inflation. Twenty-six of these trials accounted
for missing data at the individual level, either by dividing
by (1 - the estimated dropout rate) or multiplying by (1
+ the estimated dropout rate). Two trials also accounted
for missing data at the cluster level by including extra
clusters in each trial arm. Two trials mentioned sample
size inflation but were unclear if they accounted for
missing data at the cluster or individual level. Of the 21
trials that reported an expected and observed attrition
rate, one trial estimated a higher attrition rate than ob-
served, whereas 20 (95 %) estimated lower attrition rates
than observed. The mean absolute difference in observed
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attrition rate and expected was 9 % with a range of
0.1 to 23 %.
Sensitivity analysis for missing data
Fourteen (16 %) trials reported a sensitivity analysis for
missing data (Table 4), all of which reported more than
10 % missing data at the individual level. Of these, five
(36 %) used MI (none of which used multilevel strat-
egies), four (29 %) used single imputation, three (21 %)
used a complete case analysis, one (7 %) used a mixed
model, and one (7 %) used a mixed model with IPW.
Only five trials weakened the missingness assumption
of the primary analysis to carry out their sensitivity ana-
lysis by assuming MCAR in the primary analysis and
MAR in the sensitivity analysis. These five trials all used
a complete case analysis as the primary analysis. For the
sensitivity analysis, three of these trials used MI, one
used a mixed model, and one used a mixed model with
IPW. None of the trials reported using MNAR models.
Accounting for clustering in the primary analysis
The overwhelming majority of trials carried out an
individual-level analysis as the primary analysis (83, 97 %).
Mixed models were the most popular primary analysis
used for CRTs (45, 52 %). Forty-three (96 %) of these trials
accounted for clustering by adding cluster as a random ef-
fect, one trial was unclear, and one did not use cluster as a
random effect. Of the 22 (26 %) trials performing an indi-
vidual level basic inferential test or GLM, seven accounted
for clustering via robust standard errors or design effect
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Fig. 1 Flow diagram of the study selection process for the sample of 86 cluster randomized trials included in the review
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adjustment. Fourteen (16 %) trials used GEE, with all of
them accounting for clustering by using an exchangeable
correlation structure. Of these, one reported estimating
standard errors of parameters using the jack-knife method
because the number of clusters was small [33]. One (1 %)
trial carried out a descriptive analysis as the primary ana-
lysis and did not account for clustering (Table 5). Four
(5 %) trials carried out a basic inferential test or GLM at
the cluster level. Overall, 68 (79 %) trials accounted for
clustering in the primary analysis.
Thirty-four (40 %) trials carried out an unadjusted ana-
lysis, whereas five (6 %) adjusted for balance variables only
(stratification, matching, or minimization), and eight (9 %)
adjusted for baseline outcome only (sometimes referred to
as analysis of covariance (ANCOVA)). Thirty-nine (45 %)
trials adjusted for additional covariates beyond balance
variables in the primary analysis, with four of them also
adjusting for baseline values of the outcome.
Forty-six (77 %) trials reported accounting for cluster-
ing in their sample size calculations, with 41 reporting
an expected ICC or CV (two trials). Of the 13 trials that
reported an expected and observed ICC, seven (54 %)
trials estimated larger ICCs than observed, whereas six
(46 %) estimated lower ICCs than observed. The mean
absolute difference in the observed and expected ICC
was 0.1, with a range of 0.01 to 0.42.
Discussion
We performed a systematic review to assess how missing
outcome data are being handled in CRTs. Of the 86 in-
cluded CRTs, most reported some missing outcome data
in the primary analysis. Among those that reported
missing data, the median proportion of individuals with
a missing outcome at the primary analysis was 19 %. Six-
teen percent of the trials carried out a sensitivity analysis
for missing data, with all of them reporting more than
10 % missing data. Only a third of these trials weakened
the missingness assumption from the primary analysis.
Observed missing data rates generally exceeded
expected rates, which means that researchers are not
accounting enough for attrition in sample size calcula-
tions or adequately following up on participants. Fur-
thermore, only about half (55 %) of the trials with
repeated measurements used all of the outcome data in
the primary analysis. Reducing repeated data to a single
time point often generates a strong MCAR assumption
and may reduce power. Even if the primary outcome of
interest is at a particular time point, previous literature
has shown that utilizing all of the information collected
can minimize bias due to missing data [34].
The amount of detail in sample size calculations varied
widely across trials. A few did not provide enough detail
for us to indicate that a sample size calculation was per-
formed before data collection. For example, one trial
stated “sample size calculations showed 382 participants
were needed.” [35] Furthermore, accounting for clus-
tered data in sample size calculations differed among tri-
als. One trial arbitrarily chose to increase the sample
size by 30 % to account for clustering [36]. One trial
stated that clustering was not accounted for in the sam-
ple size calculation because cluster sizes were expected
to be small and within-cluster comparisons were not
considered to be clinically meaningful [37].
Along with missing individuals, missing data can also
occur at the cluster level. The removal of entire clusters
with the usual solution of complete case analysis is
wasteful and could lead to biased estimates depending
on the missing data mechanism [38]. We did not find
any studies that performed MI appropriate for clustered
data (multilevel MI). Some strategies that have been
Table 2 Proportion of clusters with missing outcome at the
primary analysis among the 86 trials included in the review
N (%)
None 59 (69)
<10 % 14 (16)
>10 % 10 (12)
Unclear 3 (3)
Table 1 General characteristics of the 86 randomly selected
cluster randomized trials published from August 2013 to July
2014
N (%)










How outcome was treated in the primary analysis
Single 50 (58)
Repeated 36 (42)





Presented sample size calculation 60 (70)
aOne trial also used matching, and another trial also used minimization
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proposed to accommodate missing data in the multi-
level setting, but none have been put to widespread use
[15, 39–41].
In comparison to Diaz-Ordaz et al.’s [28] review, we
found a higher proportion of trials reporting missing
data at the cluster (28 % versus 18 %) and individual
levels (93 % versus 48 %). This may be due to differences
in definitions of missing data or because Diaz-Ordaz was
not able to verify the amount of missing data in 31 % of
the trials. We observed a similar median cluster attrition
rate (7 % versus 10 %) and a slightly higher median indi-
vidual attrition rate (19 % versus 13 %). Of the 95 trials
with missing data, Diaz-Ordaz et al. found 66 % of the tri-
als reporting a complete case analysis, GEE, or likelihood-
based hierarchical/mixed model, whereas 18 % used single
imputation and 6 % used MI. Lastly, we found a slightly
higher proportion of trials reporting a sensitivity analysis
for missing data (16 % versus 11 %). Compared to Bell et
al.’s [7] review of 77 individually randomized controlled
trials from 2013, we found a similar proportion of trials
reporting missing data (93 % versus 95 %). However,
CRTs were subject to higher individual level missing
data rates (median 19 %, up to 90 %) compared to
individually randomized trials (median 9 %, up to
Table 3 Handling of missing data in primary analysis among






N = 14 N = 58 N = 8 N = 80
Complete case 10 31 3 44 (55)
Single imputation
Worst-case 1 2 0 3 (4)
LOCF 0 2 0 2 (2)
Baseline observation
carried forward
0 1 0 1 (1)
Multiple imputation 0 2 0 2 (2)
GEE (unweighted) 3 0 1 4 (5)
Mixed model/
hierarchical/multilevel
0 17 1 18 (22)
Othera 0 0 1 1 (1)
Unclear 0 3 2 5 (6)
Abbreviations: LOCF, last observation carried forward; GEE, generalized
estimating equation
aOne trial excluded participants who dropped out or had no baseline value;
for those who participated at both time points, the LOCF was carried out for a
missing primary outcome
Fig. 2 Distribution of the percentage of individuals with a missing outcome for the 86 trials included in the review
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70 %). Compared to the individually randomized
trials, we found a higher proportion using complete
case analysis (55 % versus 45 %) and mixed models
(22 % versus 15 %). Furthermore, we found a similar
proportion using GEE (4 % versus 5 %) and a lower
proportion using single imputation (8 % versus 27 %)
and MI (2 % versus 8 %)
More sophisticated methods are being used. Com-
pared to a review conducted by Simpson et al. [26] of 21
CRTs from 1990 to 1993, the proportion of trials that
took clustering into account in the primary analysis in-
creased over time (57 % to 78 %). In comparison with
Scott et al.’s [42] review of 150 individually randomized
trials in 2001, we found a higher percentage of CRTs
using stratification (31 % versus 13 %) and a similar per-
centage using minimization (3 % versus 4 %) compared
to individually randomized trials.
Our study has several strengths. Eligible studies were
all CRT designs, including the stepped wedge and feasi-
bility studies. In order to minimize the potential for bias
during the review process, we had pre-specified search,
study selection, and data collection strategies, all of
which were carried out by two independent reviewers.
We did not limit our sample space to journals with a
high impact factor, thereby increasing generalizability.
Three independent reviewers performed pilot testing on
several trials to create a standardized data collection
template. Our study has limitations as well. For example,
we only chose CRTs published in English, which may re-
sult in selection bias. It was difficult to identify all CRTs
because many do not include “cluster” as a term in the
title or abstract. However, our search strategy included
other frequently used terms for cluster randomization
such as “community randomized” and “group random-
ized.” Still, our review may have some selection bias, as
researchers who do not realize their studies are cluster
randomized might not follow the CONSORT guidelines,
include terms such as “cluster randomized” in the title
or abstract, or use robust techniques [27]. Additionally,
we took a random selection of the eligible CRTs, as it
was not feasible to review all 402 studies. As with any
sample, this one may not be representative of the true
population. However, a random selection minimizes the
possibility of non-representativeness. Furthermore, we
may have underestimated the amount of missing data
because we used the CONSORT flow diagram, which
may primarily report outcome sample size only. It is
possible that missing covariates in regression models re-
sulted in additional missing data and actual smaller sam-
ple sizes. Although some trials adjusted for additional
covariates beyond balance variables, nearly all were base-
line covariates such as age and gender.
In conclusion, missing data are present in the majority
of CRTs, yet handling missing data in practice remains
suboptimal. Appropriate methods to handle missing
clustered data, particularly under the MAR assumption,
should be made more accessible by methodological stat-
isticians. For example, providing appropriate software
may increase the use of such methods [43]. Moreover,
researchers and applied statisticians should keep up-to-
date with such methods in order to increase statistical
power in trials and reduce the potential for bias. Thus,
we present the following recommendations for CRTs: (1)
attempt to follow up on all randomized clusters and in-
dividuals in order to limit the extent of missing data, (2)
perform a primary analysis that is valid under a plausible
missingness assumption and that uses all observed data,
(3) perform sensitivity analyses that weaken the missing
data assumption to explore the impact of departures
made in the primary analysis, and (4) follow the CON-
SORT extension for cluster trials statement to ensure
Table 5 Primary analysis in 86 cluster randomized trials
Accounted for clusteringa Total
Primary Analysis Yes No N (%)
N (%) N (%)
Individual level:
Basic inferential test/GLM 7 (32) 15 (68) 22 (26)
GEE 14 (100) 0 (0) 14 (16)
Mixed model 43 (96) 2 (4)b 45 (52)
Otherc 0 (0) 1 (100) 1 (1)
Cluster level:
Basic inferential test/GLM 4 (100) 0 (0) 4 (5)
Abbreviations: GLM, generalized linear model; GEE, generalized
estimating equation
aThe denominator is the total number of trials performing respective
primary analysis
bOne trial was unclear
cTrial used a descriptive analysis as primary analysis
Table 4 Methods for handling missing data in sensitivity
analysis in 14 trials
Sensitivity method Primary analysis N Total N (%)
Complete case MI 2 3 (21)
Mixed model 1
Single imputation Complete case 1 4 (29)
Single imputation 1
Mixed model 2
MI Complete case 3 5 (36)
Mixed model 1
Unclear 1
Mixed model Complete case 1 1 (7)
Mixed model with IPW Complete case 1 1 (7)
Abbreviations: MI, multiple imputation; IPW, inverse probability weighting
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comprehensive reporting and transparency of methods
[10, 44].
Conclusions
This review aims to assess the extent and handling of
missing outcome data in CRTs. Despite high rates of
missing outcome data in the primary analysis, methods
used to deal with missing data in practice remain inad-
equate. Appropriate methods, which are valid under
probable missing data assumptions, should be performed
to increase the statistical power and lessen the likelihood
of bias. Sensitivity analysis with a weakened missing data
assumption should be performed to evaluate robustness
of the primary results.
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